Related Experiment Video
Updated: Jun 9, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Sequence-dependent prion protein misfolding and neurotoxicity
Pedro Fernandez-Funez1, Yan Zhang, Sergio Casas-Tinto
1Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, Florida 32610, USA. pedro.fernandez@neurology.ufl.edu
Transgenic flies reveal differences in prion protein (PrP) dynamics. Rabbit PrP is resistant to conversion, while hamster and mouse PrP show varying degrees of neurodegeneration and aggregation.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Prion diseases stem from misfolded prion protein (PrP) forming pathogenic aggregates.
- Understanding PrP conversion mechanisms is crucial for studying neurodegenerative disorders.
Purpose of the Study:
- To investigate the conformational dynamics of mammalian prion proteins (PrP) in a transgenic fly model.
- To compare PrP conversion and neurotoxicity in species susceptible and resistant to prion diseases.
Main Methods:
- Expression of hamster, mouse, and rabbit prion protein (PrP) in transgenic Drosophila melanogaster.
- Assessment of neurodegeneration and accumulation of scrapie-like PrP conformers.
Main Results:
- Rabbit PrP did not induce spongiform degeneration or convert into scrapie-like conformers.
- Hamster PrP induced significant spongiform degeneration and aggregated into scrapie-like conformers.
- Mouse PrP induced mild neurodegeneration and accumulated small amounts of scrapie-like conformers.
Conclusions:
- Mammalian PrP exhibits distinct conformational dynamics and disease-inducing potential in transgenic flies.
- The amino acid sequence likely encodes these differences in PrP conversion properties.
- Transgenic flies serve as a valuable model for studying prion protein conformational changes.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Parkinson Disease ll: Pathophysiology
Alzheimer Disease ll: Pathophysiology
Subviral Agents
Export of Misfolded Proteins out of the ER

